Posts in LSE:TET

13 shares for the future

13 shares for the future

There are plenty of shares screaming 'buy', according to companies analyst Richard Beddard, and one that looks "very, very cheap".

Director Deals - Treatt PLC (TET)

Daemmon Reeve, Chief Executive Officer, bought 403 shares in the company on the 15th December 2017 at a price of 446.50p. The Director now holds 162,615 shares.

NOTE: Awarded 604 matching shares.

Director deals data provided by www.directorsholdings.com

Director Deals - Treatt PLC (TET)

Daemmon Reeve, Chief Executive Officer, bought 403 shares in the company on the 15th December 2017 at a price of 446.50p. The Director now holds 162,615 shares.

NOTE: Awarded 604 matching shares.

Director deals data provided by www.directorsholdings.com

15 stocks in the 'buy zone'

15 stocks in the 'buy zone'

After rejigging the algorithm and reassessing every share ranked by his Decision Engine stock screener, companies analyst Richard Beddard has a lot to report on.

Treatt: Growth Continues Apace

Treatt has posted yet another year of excellent growth, with revenues up 25% and adjusted PBT up c 45%. The company has reached its FY20 financial objectives three years early, and the management has therefore updated its strategy to take the company through to the next phase. A new facility is being built in the UK, and the US site is being expanded. Both projects are on track and Treatt has now announced a share placing to fund these projects. This was always flagged as a possibility. We update our forecasts to reflect the FY17 results and the share placement. Our fair value is 515p (from 522p previously).
Edison Investment Research
6813e4c3-5316-4262-9329-eb871f6e959a
No
https://indigo.bluematrix.com/indigo/Viewer.action?info=6W079KjBqlx6SzgNoKg5AJb5WksBlcpt0qodZKmx4%2BQ%3D
Treatt plc

Can these growth stocks maintain their meteoric trajectories?

Manufacturing ingredients that enhance the flavour and fragrance of products has proven a nicely profitable niche for Treatt (LSE:TET). The shares are up 63% over the last year after a string of upgrades to forecast earnings buoyed investor sentiment.

The shares now trade on a P/E of 17, but I believe the company's ambitious growth plans and solid track record justifies this valuation. The company grew revenues by 24.5% in 2017, with profit jumping 55% to £12.9m, driven by strong growth across all of the group's categories.

Treatt profit rises; to raise £21.6m

Flavoring and fragrance provider Treatt posted a large rise in annual profit, while launching a share issue to raise £21.6m.

Pre-tax profit jumped 46% to £12.9m, as revenue increased by 25% to £109.6m.

New shares in the company will be issued at 2p each.

Ovid's shares for the future

Ovid's shares for the future

Speculators focus on extremes, leaving good firms at reasonable prices in the middle - unloved and undervalued. Here's why Richard Beddard's stocks are 'safest in the middle course'.

Treatt: A Full Year Treat(T)

Treatt has had yet another outstanding year, continuously exceeding expectations and meeting its 2020 strategic objectives three years early. The board has already approved a plan to drive the business through to 2022 that seeks to build on this success. We raise our EPS forecasts by 3% in FY17 to reflect the strong performance, though our FY18 and FY19 EPS estimates fall by 1-7% due to higher interest costs. Our DCF-derived fair value increases to 522p from 438p, which represents c 10% upside.
Edison Investment Research
55391512-09f8-458c-a638-72f7ae018d03
No
https://indigo.bluematrix.com/indigo/Viewer.action?info=6W079KjBqlyDBb1AtiazAMJ8bkTOxKISvmz8nMJUkY4%3D
Treatt plc

Treatt forecasts 24% annual revenue surge

Treatt said it has continued to perform strongly in the second half of the financial year and expects to report profit before tax and exceptional items comfortably in line with its recently-upgraded expectations.

The relatively stronger US dollar against the British pound has also had a positive impact on the group's results.